EUVIMEDEUVIMED entdecken
Crossref

Transglutaminase 2 contributes to bacterial control and inflammatory pathology in Mycoplasma pneumoniae pneumonia

Jun He, Nan Ding, Zhining Liu, Chang Liu, Feichen Xiu, Qianrui Zeng, Liubin Huang, Sha Zeng, Xuan Jiang, Xinchao Yi, Shutong Chen, Chun Li und 3 weitere

The Journal of Immunology · 02.11.2026 · 215 (11)

DOI: 10.1093/jimmun/vkag296 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Journal of Immunology, online erschienen am 19.11.2026. Verfasst von Jun He und 14 weiteren Autor:innen. Die Arbeit nennt 56 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Natural Science Foundation of Hunan Province, China.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The host response to Mycoplasma pneumoniae not only contributes to bacterial control, but can also cause acute lung pathology. The molecular drivers of this response remain incompletely defined. In this study, we identify transglutaminase 2 (TG2) as a contributor to bacterial control and acute inflammatory pathology in host defense. We observed that serum TG2 concentrations were significantly increased in pediatric patients with M. pneumoniae pneumonia. Mechanistically, in human bronchial epithelial cells, M. pneumoniae increased TG2 expression and transglutaminase activity through a TLR2-dependent pathway that engages a TG2/NF-κB/HIF-1α positive feedback loop. This feedback loop was associated with increased expression of matrix metalloproteinases and fibronectin. Infection of TG2-deficient mice with M. pneumoniae resulted in significantly attenuated lung inflammation, cytokine production, and expression of extracellular matrix remodeling proteins, but was associated with impaired bacterial control and substantially higher pulmonary pathogen loads. Bone marrow chimeras in which TG2 was absent from the recipient compartment showed the same pattern, with higher bacterial burdens and reduced inflammation relative to control chimeras. These findings identify TG2 as a mediator that couples effective bacterial control to inflammatory lung injury.

Förderung

  • National Natural Science Foundation of China
  • Natural Science Foundation of Hunan Province, China

Zitieren

APA

He, J., Ding, N., Liu, Z., Liu, C., Xiu, F., Zeng, Q., Huang, L., Zeng, S., Jiang, X., Yi, X., Chen, S., Li, C., Luo, H., Li, Y., & You, X. (2026). Transglutaminase 2 contributes to bacterial control and inflammatory pathology in Mycoplasma pneumoniae pneumonia. The Journal of Immunology, 215(11). https://doi.org/10.1093/jimmun/vkag296

Vancouver

He J, Ding N, Liu Z, Liu C, Xiu F, Zeng Q, et al. Transglutaminase 2 contributes to bacterial control and inflammatory pathology in Mycoplasma pneumoniae pneumonia. The Journal of Immunology. 2026;215(11). doi:10.1093/jimmun/vkag296

BibTeX
@article{He2026,
  author = {He, Jun and Ding, Nan and Liu, Zhining and Liu, Chang and Xiu, Feichen and Zeng, Qianrui and Huang, Liubin and Zeng, Sha and Jiang, Xuan and Yi, Xinchao and Chen, Shutong and Li, Chun and Luo, Haodang and Li, Yumeng and You, Xiaoxing},
  title = {Transglutaminase 2 contributes to bacterial control and inflammatory pathology in Mycoplasma pneumoniae pneumonia},
  journal = {The Journal of Immunology},
  year = {2026},
  volume = {215},
  number = {11},
  doi = {10.1093/jimmun/vkag296}
}
Kostenlos starten →